| Acne |
No |
| Active Half-Life |
2 days |
| Active substance |
Letrozole |
| Also known as |
Letrozole |
| Aromatization |
No |
| Blood pressure |
May cause a decrease |
| Category |
Letrozole |
| Chemical name |
Letrozole |
| Classification |
Non-steroidal aromatase inhibitor |
| Dosage |
0.5 - 2.5 mg/day |
| Dosage (medical) |
2.5 mg once daily |
| Dosage (sports) |
1.25 mg to 2.5 mg every other day |
| Dosage Unit |
Tabs |
| ean13 |
1391564747999 |
| Effects |
Reduces estrogen levels, increases luteinizing hormone (LH) and follicle-stimulating hormone (FSH) |
| FORM |
Oral |
| Formula |
C17H11N5 |
| Half-life |
Approximately 2 days |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Monitoring of blood estrogen levels and liver function tests |
| Main action |
Inhibits the enzyme aromatase, which is involved in estrogen synthesis |
| Reference |
SDRGN34 |
| Side effects |
Hot flashes, joint pain, fatigue, risk of osteoporosis |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Aromatase inhibitor |
| Tab Piece |
100 Tabs |
| Trade name |
Femara |
| Use in sports |
Used to counteract the side effects of estrogen produced by aromatizing anabolic steroids |
| Water Retention |
No |
| Packing |
Sachet |
